A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line

Abstract The current chemotherapy treatments for liver cancer have shown limited effectiveness. Therefore, there is an urgent need to develop new drugs to combat this disease more effectively. This study reports synthesis of cobalt oxide nanoparticles coated with glucose, and conjugated with Ellagic...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayda Mahmoudi, Vajiheh Zarrin Pour, Ali Salehzadeh
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-85312-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594773105442816
author Ayda Mahmoudi
Vajiheh Zarrin Pour
Ali Salehzadeh
author_facet Ayda Mahmoudi
Vajiheh Zarrin Pour
Ali Salehzadeh
author_sort Ayda Mahmoudi
collection DOAJ
description Abstract The current chemotherapy treatments for liver cancer have shown limited effectiveness. Therefore, there is an urgent need to develop new drugs to combat this disease more effectively. This study reports synthesis of cobalt oxide nanoparticles coated with glucose, and conjugated with Ellagic acid. Physicochemical characterization of Co3O4@Glu-Ellagic acid nanoparticles was done using FT-IR, XRD, SEM, TEM, TGA, EDS-mapping, DLS, and zeta potential analyses, and the investigation of their anticancer potential on liver cancer cell lines involved the use of MTT, flow cytometry, and cell cycle analysis. The synthesized nanoparticles were somewhat spherical, arranged in a relatively cluster-shaped form, and were 33–46 nm in diameter. The zeta potential and particle hydrodynamic size were − 5.43 and 169 nm, respectively and had no elemental impurity. Also, the synthesized particles had proper thermal stability at temperatures below 100 °C. Treating cancer cells with the nanoparticles considerably increased ROS levels by 2.6 folds. Compared to normal human cells, Co3O4@Glu-Ellagic acid nanoparticles showed significantly higher toxicity for liver cancer and the 50% inhibitory concentration was 94 and 187 µg/mL for the cancer and normal cells, respectively. Co3O4@Glu-Ellagic acid increased cell apoptosis, from 0.87 to 9.24%, and the cells were mainly arrested at the G0/G1 and G2/M phases. Overall, the present work indicated that Co3O4@Glu-Ellagic acid has antiproliferative effects on liver cancer cells through an increased oxidative stress level, inhibition of cell cycle, and apoptosis induction.
format Article
id doaj-art-7a3344407c534afd98303d4743952eed
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-7a3344407c534afd98303d4743952eed2025-01-19T12:20:48ZengNature PortfolioScientific Reports2045-23222025-01-0115111410.1038/s41598-025-85312-8A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell lineAyda Mahmoudi0Vajiheh Zarrin Pour1Ali Salehzadeh2Department of Biology, Damghan Branch, Islamic Azad UniversityDepartment of Biology, Damghan Branch, Islamic Azad UniversityDepartment of Biology, Rasht Branch, Islamic Azad UniversityAbstract The current chemotherapy treatments for liver cancer have shown limited effectiveness. Therefore, there is an urgent need to develop new drugs to combat this disease more effectively. This study reports synthesis of cobalt oxide nanoparticles coated with glucose, and conjugated with Ellagic acid. Physicochemical characterization of Co3O4@Glu-Ellagic acid nanoparticles was done using FT-IR, XRD, SEM, TEM, TGA, EDS-mapping, DLS, and zeta potential analyses, and the investigation of their anticancer potential on liver cancer cell lines involved the use of MTT, flow cytometry, and cell cycle analysis. The synthesized nanoparticles were somewhat spherical, arranged in a relatively cluster-shaped form, and were 33–46 nm in diameter. The zeta potential and particle hydrodynamic size were − 5.43 and 169 nm, respectively and had no elemental impurity. Also, the synthesized particles had proper thermal stability at temperatures below 100 °C. Treating cancer cells with the nanoparticles considerably increased ROS levels by 2.6 folds. Compared to normal human cells, Co3O4@Glu-Ellagic acid nanoparticles showed significantly higher toxicity for liver cancer and the 50% inhibitory concentration was 94 and 187 µg/mL for the cancer and normal cells, respectively. Co3O4@Glu-Ellagic acid increased cell apoptosis, from 0.87 to 9.24%, and the cells were mainly arrested at the G0/G1 and G2/M phases. Overall, the present work indicated that Co3O4@Glu-Ellagic acid has antiproliferative effects on liver cancer cells through an increased oxidative stress level, inhibition of cell cycle, and apoptosis induction.https://doi.org/10.1038/s41598-025-85312-8ApoptosisEllagic acidFlow cytometryLiver cancerCo3O4@Glu-Ellagic acid
spellingShingle Ayda Mahmoudi
Vajiheh Zarrin Pour
Ali Salehzadeh
A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
Scientific Reports
Apoptosis
Ellagic acid
Flow cytometry
Liver cancer
Co3O4@Glu-Ellagic acid
title A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
title_full A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
title_fullStr A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
title_full_unstemmed A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
title_short A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
title_sort novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line
topic Apoptosis
Ellagic acid
Flow cytometry
Liver cancer
Co3O4@Glu-Ellagic acid
url https://doi.org/10.1038/s41598-025-85312-8
work_keys_str_mv AT aydamahmoudi anovelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline
AT vajihehzarrinpour anovelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline
AT alisalehzadeh anovelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline
AT aydamahmoudi novelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline
AT vajihehzarrinpour novelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline
AT alisalehzadeh novelcobaltoxidenanoparticleconjugatedwithellagicacidarreststhecellcycleinhumanlivercancercellline